Despite the fact that the pandemic’s severity has decreased, a new COVID variant has re-ignited a wave of uncertainty. COVID cases are reported in the country on a daily basis. Individuals and businesses alike are fearful of the upcoming 4th wave, as attempts to reestablish some normalcy are underway. As the number of daily new infections rises, Shycocan, a niche tech-solution company, introduces a device that ensures “Virus Attenuation,” which is being widely adopted by businesses today to ensure business continuity in the face of uncertainty.

Shycocan is the world’s first Virus Attenuation Device, with a 99.9% efficacy in preventing Coronavirus and other viral infections in indoor spaces. It is completely safe for humans, animals, and the environment. To back up their claims, they have a number of virology lab test reports. It is a CE Class I device that complies with the regulatory requirements of a number of countries around the world. Shycocan has been tested for SARS-COV-2 (Covid 19 virus) at the CCMB in Hyderabad, a CSIR laboratory, as well as at TNO in the Netherlands (one of the top Research and testing facilities in Europe).

Shycocan has been shown to disable the virus up to 96 percent and 95 percent, respectively, in these tests. Other coronaviruses that the device has been tested on include Avian, Equine Arteritis, and MS2 Bacteriophage, which is a WHO-approved surrogate virus for testing both Coronavirus and Influenza. These test results show 100% efficacy against airborne viruses and 99.9% efficacy against surface-borne viruses.

 In Eastern India, Shycocan has seen steady growth. Shycocan Corporation was founded in July 2020. Shycocan has been installed in over 30,000 units around the world, with the majority of these installations taking place in the last 12-18 months. Until now, we’ve sold a significant number in the East and North East. Corporates, individuals, and government offices such as the Meghalaya Legislative Assembly and the Arunachal Pradesh Legislative Assembly are among our clients. We would be happy to accommodate an onset of manufacturing in that state for both domestic and global consumption if a state considers mass adoption of the device” said Mr. Alok Sharma, founder of Shycocan and former MD of Apple India.

Technology Details:

Coronaviruses are viruses that are encased in a positively charged capsid shell, whereas human cell membranes are negatively charged. The Coronavirus binds to the human cell, infuses its RNA, and uses its cellular mechanism to duplicate itself, much like a photocopy machine. Shycocan works by neutralizing the virus’s positive charge, preventing Coronavirus particles from attaching themselves to a host cell. This specialized device’s core is made of a super-alloy that was developed after a decade of research and produces high-intensity photons when excited. These photons emit electrons when they collide with solid surfaces in space, such as particles in the air, tables, chairs, walls, and so on. The negatively charged electrons attach themselves to the Coronavirus’s positive shell, neutralizing it and preventing it from infecting others. This is referred to as “Virus Attenuation.”

This virus attenuation is effective against both surface and airborne Coronaviruses, as well as the Influenza virus family. Anyone touching a previously infected surface in the presence of Shycocan will not contract the virus. This technology provides far more protection and safety than any other available technology. Shycocan has a longer lifespan, requires less maintenance, and uses less electricity because the super-alloy that generates photons does not deteriorate. A single device can effectively cover 1000 square feet. This device can protect you from current and future pandemics caused by Coronavirus and Influenza virus variants. Shycocan will not only ensure business continuity during viral outbreaks but will also provide ongoing protection.